"
Team:MIT/Results/
From 2011.igem.org
(Difference between revisions)
| Line 57: | Line 57: | ||
<h1>Parts Characterizations</h1> | <h1>Parts Characterizations</h1> | ||
<p>The characterization of newly constructed biological parts is </p> | <p>The characterization of newly constructed biological parts is </p> | ||
| + | <h2>List of characterizations</li> | ||
| + | <ul> | ||
| + | <li>rtTA3/TRE promoter</li> | ||
| + | <li>Gal4/UAS promoter</li> | ||
| + | <li>LacI/Hef1a-LacO repressor</li> | ||
| + | <li>Delta-Notch interaction</li> | ||
| + | <li>CMV-TetO promoter</li> | ||
| + | <li>Mnt-VP16/Mnt promoter</li> | ||
| + | <li>CI434-VP16/CI434 promoter</li> | ||
| + | <li><em>Gal4->LacI-|rtTA3->Reporter cascade</em></li> | ||
| + | </ul> | ||
Revision as of 07:01, 26 September 2011
Parts Summmary
Registry of parts coming soon!
Parts Characterizations
The characterization of newly constructed biological parts is
